Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Jiri Faustmann
Jiri Faustmann, Opava-6 CZ
| Patent application number | Description | Published |
|---|---|---|
| 20080254520 | Method for reducing impurity level in mycophenolic acid fermentation - The present invention relates to methods for reducing impurities of mycophenolic acid during fermentation by controlling the level of carbon source during fermentation of mycophenolic acid and for the isolation and use as a standard marker of the impurity homo-mycophenolic acid. | 10-16-2008 |
| 20090012295 | Amorphous Erlotinib, processes for the preparation thereof, and processes to prepare additional forms of Erlotinib - The present invention provides amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib. | 01-08-2009 |
| 20090118297 | POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF - Provided is dasatinib, solvates thereof and their crystalline forms, methods for their preparation, and pharmaceutical compositions thereof. | 05-07-2009 |
| 20100004449 | CRYSTALLINE FORMS OF ERLOTINIB BASE AND ERLOTINIB HCL - The preparation of crystalline Erlotinib base form G2 is described. This crystalline form can be converted to an Erlotinib salt, such as Erlotinib HCl, which can be used in the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). | 01-07-2010 |
| 20100130458 | Polymorphs of fluticasone furoate and process for preparation thereof - Provided are polymorphs of fluticasone furoate and processes for preparation thereof. | 05-27-2010 |
Jiri Faustmann, Opava CZ
| Patent application number | Description | Published |
|---|---|---|
| 20080262223 | Isolation of Galanthamine From Biological Material - The subject matter of present invention relates to the process for isolation and purification of galanthamine and its derivatives produced by numerous plants. | 10-23-2008 |
| 20080293110 | Process for Isolation of Mycophenolic Acid - Mycophenolic acid can be isolated from fermentation broth easily with low consumption or organic solvents to produce mycophenolic acid that is surprisingly high in purity. The process can be accomplished by addition of a suitable base to the whole fermentation broth. i.e., a suspension obtained by submerged cultivation of a microorganism producing mycophenolic acid, to increase pH of the liquid phase to the value from about (9) to about (13). Mycophenolic acid is thus extracted from the mycelium to the liquid phase and the exhausted mycelium can be separated easily by filtration. | 11-27-2008 |
| 20090124642 | Crystalline forms of Erlotinib HCI and formulations thereof - The invention provides a novel crystalline form of Erlotinib HCl, processes for its preparation, and formulations thereof. | 05-14-2009 |
| 20090131665 | Process for the preparation of crystalline forms A, B and pure crystalline form a of erlotinib HCI - The invention provides processes for preparing crystalline Forms A, B and pure crystalline Form A of Erlotinib hydrochloride. | 05-21-2009 |
| 20090264438 | Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form alpha - Solvates and crystalline forms of imatinib mesylate are described. Further, methods for preparing such solvates and crystalline forms of imatinib mesylate are described. | 10-22-2009 |